Nom du produit:2-(5-bromoquinoxaline-1,4-diium-6-yl)guanidine;chloride
IUPAC Name:8-bromo-7-[(diaminomethylidene)amino]quinoxaline-1,4-diium chloride
- CAS:1797986-78-7
- Formule moléculaire:C9H10BrClN5
- Pureté:95%+
- Numéro de catalogue:CM816157
- Poids moléculaire:303.57
Unité d'emballage |
Stock disponible |
Prix($) |
Quantité |
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:1797986-78-7
- Formule moléculaire:C9H10BrClN5
- Point de fusion:-
- Code SMILES:[Cl-].NC(N)=NC1=C(Br)C2=[NH+]C=C[NH+]=C2C=C1
- Densité:
- Numéro de catalogue:CM816157
- Poids moléculaire:303.57
- Point d'ébullition:
- N° Mdl:
- Stockage:
Category Infos
- Quinoxalines
- Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.